Houdini Bio — Company Profile & Funding History

Product

The company uses machine learning and research into the HUSH protein complex to redesign DNA while preserving the biological function it is intended to deliver.

Its platform is designed for developers of gene therapies, cell therapies and biomanufacturing processes seeking more durable gene expression.

Funding history

1 round · 0 with disclosed amounts

Announced	Round	Amount	Investors
Jun 19, 2026	Pre-seed; equity allocation undisclosed	Undisclosed	SCVC — LeadCambridge Enterprise Ventures — ParticipantDeep Science Ventures — Participant

Investors

SCVCLed Pre-seed; equity allocation undisclosed Cambridge Enterprise VenturesJoined Pre-seed; equity allocation undisclosed Deep Science VenturesJoined Pre-seed; equity allocation undisclosed

Coverage

Jun 19, 2026Houdini Bio · Pre-seed; equity allocation undisclosed

Similar companies

Ares IntelligenceAres Intelligence helps enterprises decide where to apply AI by interviewing employees about their work and turning those conversations into a prioritised adoption plan.€2.6M · Undisclosed

LupaLupa connects scientific publications, patents and industry information to help researchers and technical businesses find relevant knowledge and commercial opportunities.CHF 150K · Venture Kick programme completion

ALLOXALLOX combines high-throughput genetics, experimental biology and AI to find functional sites on proteins and develop targeted small-molecule medicines.$10.5M · Seed

Sources

bioindustry.org ↗